Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cells

Main text

(Molecular Therapy: Nucleic Acids 27, 439–455; March 2022)

In the originally published version of this article, the image of the 7th lane “NF-κB (p65)” of Figure 7F was inadvertently replaced with an incorrect version during the upload process of pictures in Figure 7F. The corrected Figure 7 is below, and the authors apologize for this error.

Figure 7. Influence of DOCK2 mRNA editing on tumorigenesis of melanoma stem cells in vivo (corrected)